TW202322827A - 氧化鎂錠劑 - Google Patents

氧化鎂錠劑 Download PDF

Info

Publication number
TW202322827A
TW202322827A TW111130617A TW111130617A TW202322827A TW 202322827 A TW202322827 A TW 202322827A TW 111130617 A TW111130617 A TW 111130617A TW 111130617 A TW111130617 A TW 111130617A TW 202322827 A TW202322827 A TW 202322827A
Authority
TW
Taiwan
Prior art keywords
cellulose
lozenge
magnesium oxide
additives
mass
Prior art date
Application number
TW111130617A
Other languages
English (en)
Chinese (zh)
Inventor
山地徹
Original Assignee
日商世拓拉斯控股公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商世拓拉斯控股公司 filed Critical 日商世拓拉斯控股公司
Publication of TW202322827A publication Critical patent/TW202322827A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW111130617A 2021-08-20 2022-08-15 氧化鎂錠劑 TW202322827A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021-134883 2021-08-20
JP2021134883A JP7340572B2 (ja) 2021-08-20 2021-08-20 酸化マグネシウム錠剤

Publications (1)

Publication Number Publication Date
TW202322827A true TW202322827A (zh) 2023-06-16

Family

ID=85240721

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111130617A TW202322827A (zh) 2021-08-20 2022-08-15 氧化鎂錠劑

Country Status (6)

Country Link
US (1) US20250127725A1 (enExample)
EP (1) EP4389133A4 (enExample)
JP (2) JP7340572B2 (enExample)
CN (1) CN117835990A (enExample)
TW (1) TW202322827A (enExample)
WO (1) WO2023022078A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7742381B2 (ja) * 2023-06-21 2025-09-19 セトラスホールディングス株式会社 錠剤の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4015485B2 (ja) * 2001-08-27 2007-11-28 協和化学工業株式会社 制酸・緩下用錠剤
AR065096A1 (es) * 2007-02-01 2009-05-13 Takeda Pharmaceutical Preparacion solida
JP5499599B2 (ja) * 2008-10-01 2014-05-21 大正製薬株式会社 アセトアミノフェン含有錠剤
WO2011030659A1 (ja) * 2009-09-08 2011-03-17 協和化学工業株式会社 制酸・緩下用錠剤
TWI564008B (zh) * 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 難溶性藥物之溶解性改善製劑
US10166219B2 (en) * 2012-07-27 2019-01-01 Redhill Bipharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
KR20150019620A (ko) * 2013-08-14 2015-02-25 삼성디스플레이 주식회사 유기발광 표시 장치
JP6182023B2 (ja) * 2013-08-30 2017-08-16 アサヒグループ食品株式会社 酸化マグネシウム含有錠剤及びその製造方法
TWI724629B (zh) * 2018-11-16 2021-04-11 日商協和化學工業股份有限公司 緩瀉用錠劑

Also Published As

Publication number Publication date
EP4389133A4 (en) 2025-07-30
US20250127725A1 (en) 2025-04-24
EP4389133A1 (en) 2024-06-26
JP7340572B2 (ja) 2023-09-07
WO2023022078A1 (ja) 2023-02-23
CN117835990A (zh) 2024-04-05
JP2023028906A (ja) 2023-03-03
JP2023099857A (ja) 2023-07-13

Similar Documents

Publication Publication Date Title
JP6629835B2 (ja) 直接圧縮可能なポリビニルアルコール
US9446137B2 (en) Composite particles which contain both cellulose and inorganic compound
JP5753661B2 (ja) 低置換度ヒドロキシプロピルセルロース水分散液を用いた湿式造粒打錠法
US10426838B2 (en) Composite particles including cellulose, inorganic compound, and hydroxypropyl cellulose
JP2005513099A (ja) アジスロマイシンの直接的に圧縮可能な配合品
WO2003018034A1 (fr) Comprimes antiacides et laxatifs
JP2012001473A (ja) 固形製剤
JPWO2017217491A1 (ja) 口腔内崩壊錠
TW202322827A (zh) 氧化鎂錠劑
JP2003146889A (ja) 制酸・緩下用錠剤
JP5442609B2 (ja) セルロース組成物
TW200303219A (en) Tablets having improved tabletting characteristics and process for producing the same
JP7652778B2 (ja) 錠剤およびその製造方法
JP2024050466A (ja) 固形組成物
JP3884056B1 (ja) 口腔内速崩錠の製造方法
JP5160156B2 (ja) 栄養機能食品錠剤
WO2009151090A1 (ja) 炭酸カルシウム含有速崩壊性製剤
JP2008037853A (ja) イソマルトを含有する速崩壊性医薬品固形製剤
JP6296828B2 (ja) ヒアルロン酸を含有する造粒物、該造粒物を用いて製造される錠剤及び膨潤抑制方法
JP2006022060A (ja) 制酸・緩下用水分散液およびそのための錠剤
JP2020094023A (ja) 賦形剤顆粒、錠剤及び錠剤の製造方法
JP6660694B2 (ja) シリマリン含有錠剤
JP5772169B2 (ja) イプリフラボン含有直打錠剤
CN105943525A (zh) 一种保肝药物组合物
JP2017165724A (ja) アルキルセルロースを含む固形製剤及びその製造方法